SB
Salish Bioscience Inc.
salishbio.com
Website unreachable since Oct 27, 2026
The startup develops biopsy technology that analyzes circulating free DNA (cfDNA) from patient samples to provide oncologists with actionable insights for cancer management. This approach enhances patient care by enabling more precise treatment decisions based on genetic information derived from non-invasive testing.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops biopsy technology that analyzes circulating free DNA (cfDNA) from patient samples to provide oncologists with actionable insights for cancer management. This approach enhances patient care by enabling more precise treatment decisions based on genetic information derived from non-invasive testing.